Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

Ann Rheum Dis. 2002 Jun;61(6):560-1. doi: 10.1136/ard.61.6.560.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal* / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Behcet Syndrome / complications
  • Behcet Syndrome / drug therapy*
  • Humans
  • Infliximab
  • Male
  • Recurrence
  • Retinitis / complications
  • Retinitis / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab